FDA Investigator Clinton J Lott

Clinton J Lott has conducted inspections on 35 sites in 7 countries as of 11 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
35
Last Inspection Date:
11 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100006617
Countries of Inspections:
China, United States of America, Dominican Republic, India, Canada, Brazil, Colombia
FDA Investigators that have inspected at least one site in common with Clinton J Lott:
Ann B Borromeo, Bonnie E Conley, Bonnie E Pierson, Brandon C Heitmeier, Brandon C Hernandez, Brentley S Collins, Brittny C Cargo, Brooke K Higgins, Burnell M Henry, Camerson E Moore, Caryn M Mcnab, CDR Ileana Barreto Pettit, Charisse K Green, Charles D Brown, Chauncey A Stephens, Cherie T Parker, Claire M Minden, Clifton C Francis, Cynthia L Bolte, Cynthia L Medlin, Daniel L Aisen, Daphne A Videau, David R Heiar, Demario L Walls, Dennis Cantellops Paite, Deyaa Shaheen, Dorothy P Kramer, Dr. S Nar Ali, PhD, Eddie J Rigsby, Edward H Maticka, Erika V Butler, George J Flynn, George Pyramides, Geraldine D Sanders, Goran Periz, PhD, Grant D Jones, Gretchen M Laws, James A Liubicich, Jared P Stevens, Jason D Abel, Jennifer L Huntington, Jennifer Lalama, Jessica L Pressley, Jessica M Simpson, PhD, Jessica P Mcalister, Joanne E King, Joel D Hustedt, John E Russell, Jr, June P Page, Justin N Henson, Kathleen D Culver, Kayla V Sprague, Kellia N Hicks, Kenneth R Merritt, Kerry Ann Latham, Kimberly L Mcmillan, Kip J Hanks, Krista W Whitten, Lacey J Chessor, Lakisha N Morton, Laura L Staples, Libia M Lugo, Linda A Gregory Duty, Lindsay H Bertling, Lisa R Whitt, Liza L Quiles, Llopis, Logan T Williams, Luis A Dasta, Mahaffey, Marcus A Ray, Maressa L Mills, Marie A Fadden, Marie F Morin, Mark W Rivero, Markeesa M Scales, Martrice A Packer, Marvin D Jones, Mary A Millner, Matthew B Casale, Michael A Charles, Michael A Taylor, Nadia V Simmons, Nicholas P Diorio, Nicole E Knowlton, Oluwasefunm Agbanigo, Parul M Patel, Rafael Nevarez Nieves, Regan T Harp, Regina T Brown, Richard G Fochesato, Robert D Tollefsen, S Michaelith Smith, Samantha J Bradley, Samina S Khan, Sandra I Gaul, Satheesh Thomas, Scott N Lim, Scott T Ballard, Sharon K Thoma, PharmD, Shelby N Turner, Shondra N Gipson, Sidney M Smith, Simone E Pitts, Stephen D Brown, Stephen G Mclane, Steven A Brettler, Steven A Gonzales, Steven D Dittert, Susan O Oladeji, Susanna E Ford, Syed N Ali, Tenzin Jangchup, Thomas W Gordon, Timothy H Vo, Travis E Chapman, Veronica Fuentes, MS, Wayne S Fortenberry, Zachary L Miller, Zada L Giles

Clinton J Lott's Documents

Publish Date Document Type Title
November, 2021 FDA 483 Allay Pharmaceuticals, LLC - Form 483, 2021-11-15
September, 2023 EIR Yichang Sanxia Pharmaceutical Co., Ltd. - EIR, 2024-01-19
December, 2021 FDA 483 Eastman Chemical Company - Form 483, 2021-12-01
October, 2023 FDA 483 Fidelitone Order Fulfillment, LLC - Form 483, 2023-10-26
April, 2022 FDA 483 Response TriRx Huntsville Pharmaceutical Services, LLC - Form 483R, 2022-04-01
August, 2022 FDA 483 Midlab Incorporated - Form 483, 2022-08-05
January, 2023 FDA 483 RWM TECHNOLOGIES LLC - Form 483, 2023-01-13
August, 2021 FDA 483 Monarch PCM, LLC - Form 483, 2021-08-20
April, 2022 FDA 483 TriRx Huntsville Pharmaceutical Services, LLC - Form 483, 2022-04-01
November, 2022 FDA 483 Consumer Product Partners, LLC - Form 483, 2022-11-07
December, 2021 EIR Eastman Chemical Company - EIR, 2021-12-01
July, 2021 FDA 483 Consumer Product Partners, LLC - Form 483, 2021-07-23
November, 2023 FDA 483 Galbraith Laboratories, Inc. - Form 483, 2023-11-16
August, 2021 FDA 483 Response People's Custom Rx and Clinical Care, LLC - Form 483R, 2021-08-05
May, 2022 FDA 483 GCP Laboratories - Form 483, 2022-05-13
August, 2021 FDA 483 People's Custom Rx and Clinical Care, LLC - Form 483, 2021-08-05
March, 2022 FDA 483 Olympia Compounding Pharmacy - Form 483, 2022-03-02
August, 2024 FDA 483 Alcon Research LLC - Form 483, 2024-08-30
July, 2023 FDA 483 AKI, Inc. dba Arcade Beauty - Form 483, 2023-07-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more